Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
 A method of managing a patient having an accumulation of mucoid, mucopurulent or purulent material containing glycosaminoglycans, the method comprising the step of administering at least one glycosaminoglycans degrading enzyme to the patient in an amount therapeutically effective to reduce at least one of the following: the visco-elasticity of the material, pathogens infectivity and inflammation. An article of manufacture comprising an inhaler including, as an active ingredient, at least one glycosaminoglycans degrading enzyme for generating aerosols including the enzyme for management a patient having an accumulation of mucoid, mucopurulent or purulent material containing glycosaminoglycans. 
Insight Strategy & Marketing Ltd.
A A C A G A G C C G C A
A61K A61K C12N A61M G01N A61K G01N C12Y C07K G01N C12Y A61K
inventional additional inventional inventional additional inventional additional inventional inventional inventional inventional additional
Oron
Yacoby-Zeevi